Avanos Medical (AVNS) Other Non-Current Liabilities (2013 - 2026)

Avanos Medical's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $14.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 213.33% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $14.1 million (up 213.33% YoY), while the FY2025 annual figure was $13.5 million, up 206.82% from the prior year.
• Other Non-Current Liabilities came in at $14.1 million for Q1 2026 at Avanos Medical, up from $13.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $28.0 million in Q1 2022 to a low of $4.3 million in Q2 2025.
• A 5-year average of $14.9 million and a median of $14.1 million in 2026 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities slumped 59.05% in 2025 and surged 213.33% in 2026, its largest moves.
• Avanos Medical's Other Non-Current Liabilities stood at $20.5 million in 2022, then sank by 51.22% to $10.0 million in 2023, then slumped by 56.0% to $4.4 million in 2024, then surged by 206.82% to $13.5 million in 2025, then climbed by 4.44% to $14.1 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $14.1 million, $13.5 million, and $20.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison